NCT03403530View on ClinicalTrials.gov

Efficacy of IgM Rich Immunoglobulin With Antibiotics for Bacterial Sepsis in Very Low Birth Weight Preterm Neonates

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 30, 2018

Primary Completion Date

June 30, 2018

Study Completion Date

September 30, 2018

Conditions

Neonatal SEPSISVery Low Birth Weight Baby

Interventions

DRUG

IgM rich Immunoglobin

the 'IgM rich immunoglobn' is the normal human immunoglobin containing Human plasma protein 50mg/ml of which immunoglobin is atleast 95% Immunoglobin M (IgM) 6mg Immunoglobin A (IgA) 6mg Immunoglobin G (IgG) 38mg

Trial Locations (1)

364002

NICU, Sir T Hospital, Bhavnagar, Bhavnagar

All Listed Sponsors

lead

Sir Takhtasinhji General Hospital

OTHER_GOV

NCT03403530 - Efficacy of IgM Rich Immunoglobulin With Antibiotics for Bacterial Sepsis in Very Low Birth Weight Preterm Neonates | Biotech Hunter | Biotech Hunter